Menu Search
Equities

Enervit SpA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0N9T:LSE

Enervit SpA

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta0.3357
Data delayed at least 20 minutes, as of Aug 08 2022.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Enervit SpA is an Italy-based company engaged in the sports and nutrition market. It researches, develops and commercializes food supplements. The Company’s product lines include Enervit, a line of supplements for sport, efficiency, and muscular recovery before, during and after sports activity; Enerzona, a food supplement line that targets the wellness market, which includes snacks, diet food and drinks, among others; EnervitProtein, which includes products aimed at the Health & Diet market; Gymline, which is a product line allowing to maintain the muscle tone and muscle development. It operates an online shop. Its products are exported to over 20 countries globally. Its products are manufactured in facility located in Zelbio in Italy. It operates through Zest 12 SA, Equipe Enervit Srl and SLORFELDT TRADING AB.

  • Revenue in EUR (TTM)99.75m
  • Net income in EUR4.45m
  • Incorporated--
  • Employees250.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.